CN102337254B - Mutant of beta-galactosidase and preparation method and application thereof - Google Patents
Mutant of beta-galactosidase and preparation method and application thereof Download PDFInfo
- Publication number
- CN102337254B CN102337254B CN2011102473383A CN201110247338A CN102337254B CN 102337254 B CN102337254 B CN 102337254B CN 2011102473383 A CN2011102473383 A CN 2011102473383A CN 201110247338 A CN201110247338 A CN 201110247338A CN 102337254 B CN102337254 B CN 102337254B
- Authority
- CN
- China
- Prior art keywords
- mutant
- beta
- galactosidase enzymes
- galactosidase
- sulfolobus solfataricus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a mutant of beta-galactosidase and a preparation method and application thereof. In the invention, phenyl alanine close to the active center of beta-galactosidase of sulfolobussolfataricus is mutated into tyrosine to obtain a mutant enzyme F441Y. Under the optimized enzymatic conversion condition of the mutant enzyme, the yield of galactooligosaccharide produced by the mutant enzyme F441Y is up to 61 percent, which is about 10 percent higher than that of a wild enzyme. According to the invention, increase in the yield of galactooligosaccharide is realized, and a higher industrial value is achieved.
Description
Technical field
The present invention relates to a kind of beta-galactosidase enzymes mutant and preparation method thereof, after amino acid is undergone mutation near the site, active centre, obtain the active beta-galactosidase enzymes that improves, belong to genetically engineered and enzyme engineering field.
Technical background
Oligomeric galactose (GOs) is a kind of new type functional oligose, has been applied in the industries such as infant food, bakery, beverage at present.According to statistics, the Japan at present annual production of oligomeric galactose reaches 6500~7000 tons, only is lower than oligomeric isomaltose, but annual sales amount is first of all functions oligose.The America and Europe, people are also growing to the demand of oligomeric galactose.In China, oligomeric galactose or an emerging industry not yet form fairly large.After " 95 ", at Yucheng, Shandong, the ground such as Guangdong Jiangmen have just begun the production of oligomeric galactose successively, but output is limited.
Beta-galactosidase enzymes is the main enzyme of using of industrial Production by Enzymes oligomeric galactose.Beta-galactosidase enzymes acts on β (1 → 4) glycosidic link of lactose, forms galactosyl-enzyme complex, and under the glycosides vigor that the turns effect of this enzyme, mixture further is combined with semi-lactosi, disaccharides or trisaccharide, generates oligomeric galactose.The beta-galactosidase enzymes in different microorganisms source is because nature is different, and synthetic GOs ability also there are differences, as derives from
E. coli,
A. nigerThe hydrolytic activity of beta-galactosidase enzymes stronger, and derive from
B. circulans,
A. oryzae,
Kluyveromyces lactisBeta-galactosidase enzymes the stronger glycosides activity that turns is then arranged.At present, domestic a lot of to beta-galactosidase enzymes research, but mostly be the research of its hydrolysis aspect, turn glycosides active aspect the research relative deficiency,, and industrialization promotion is few, has limited the raising of oligomeric galactose production capacity.
Used in the present invention deriving from
Sulfolobus solfataricusAlthough the beta-galactosidase enzymes of P2 can be realized the High-efficient Production of oligomeric galactose in conversion process, rear extraction process is still indispensable.How to improve substrate conversion efficiency, save cost, extraction process will become the research direction of beta-galactosidase enzymes after simplifying.
Summary of the invention
The invention provides a kind of beta-galactosidase enzymes mutant, this mutant be with sulphur ore deposit sulfolobus solfataricus (
Sulfolobus solfataricus) beta-galactosidase enzymes (NCBI numbering: near AAK43121) the amino acid whose replacement active centre, compare with its parental generation beta-galactosidase enzymes, it has higher transformation efficiency to lactose.
Described beta-galactosidase enzymes mutant is that 441 amino acids phenylalanines sport tyrosine, called after F441Y.
The present invention is applied to the production of oligomeric galactose, and optimum temperuture is 70 ℃, and optimal pH is 6.5.
The present invention has optimized the enzymatic conversion condition of mutant enzyme on the basis of the mutant strain that makes up, realized the raising of oligomeric galactose output, has higher industrial value.Use this mutant to produce oligomeric galactose, under optimum enzymatic conversion condition, the productive rate of the oligomeric galactose that mutant enzyme F441Y produces reaches 61%, and wilder enzyme is high by about 10%.
Description of drawings
Fig. 1 utilizes wild enzymatic conversion lactose to generate the optimum temperuture of oligomeric galactose;
Fig. 2 utilizes mutant enzyme to transform the optimum temperuture that lactose generates oligomeric galactose;
Fig. 3 utilizes wild enzymatic conversion lactose to generate the suitableeest Ph of oligomeric galactose;
Fig. 4 utilizes mutant enzyme to transform the optimal pH that lactose generates oligomeric galactose.
Embodiment
Embodiment 1: the preparation of the wild beta-galactosidase enzymes of this example explanation.
, beta-galactosidase enzymes the clone
Cultivate sulphur ore deposit sulfolobus solfataricus P2(available from ATCC, ATCC numbering: 35095), and extract its total DNA.
Gene according to the beta-glycosidase of sulphur ore deposit sulfolobus solfataricus
LacSGene (NCBI numbering: AE006641) design primer:
Forward primer P1:GTCTG
CATATGTACTCATTTCCAAATAGC (underscore is restriction enzyme site)
Reverse primer P2:GAAT
CTCGAGTTAGTGCCTTAATGGCTTTAC (underscore is restriction enzyme site)
Utilize above-mentioned primer, take total DNA of sulphur ore deposit sulfolobus solfataricus P2 as template, the pcr amplification beta-galactosidase gene, reaction is carried out in 50 μ L systems.Reaction conditions is: 94 ℃ of denaturation 4 min; Carry out subsequently 30 circulations (94 ℃ of 10 s, 60 ℃ of 5 s, 72 ℃ of 1min50s); 72 ℃ are extended 10 min; Last 4 ℃ of insulations.The PCR fragment that amplification obtains, after glue reclaims, be connected with pMD18-T simple carrier, and will connect product and be converted into e. coli jm109, it is dull and stereotyped that converted product is coated the LB that contains the 100mg/L penbritin, through 37 ℃ of overnight incubation, choose 5 bacterium colonies on the flat board, access LB liquid nutrient medium, extracting plasmid and order-checking behind the 8h, the result is correct.
, beta-galactosidase enzymes expression and preparation:
With plasmid obtained above and pT7-7 carrier, carry out NdeI and XhoI double digestion, enzyme is cut product after glue reclaims, spend the night with 16 ℃ of connections of T4 ligase enzyme, connect product and be converted into e. coli jm109, through 37 ℃ of overnight incubation, select transformant and in the LB liquid nutrient medium that contains the 100mg/L penbritin, cultivate, extracting plasmid behind the 8h obtains the lacS/pT7-7 plasmid of enrichment.
Plasmid lacS/pT7-7 is transformed e. coli bl21 (DE3) cell, selecting transformant 37 ℃ of liquid culture in LB substratum (containing 100 μ g/mL penbritins) spends the night, 37 ℃ of rear access TB fermentation broth (containing 100 μ g/mL penbritins) are cultivated behind 2 h with 4 mg/L IPTG(isopropylthio-β-D galactosides) induce, be cooled to 25 ℃ of constant temperature culture 20 h.
Fermented liquid is in 4 ℃, and centrifugal 10 min of 8000 rpm collect thalline, uses the potassium phosphate buffer of pH 6.5 50mmol/L of equal volume to redissolve.Water-bath 30min in 80 ℃ of shaking baths, the centrifugal 20min of rear 10000rpm removes precipitation, collects supernatant liquor, obtains purer wild enzyme.
Embodiment 2: the preparation of this example explanation mutant enzyme F441Y.
, rite-directed mutagenesis
Utilize the fast PCR technology, the rite-directed mutagenesis of single mutation F441Y: expression vector
LacS/ pT7-7 is template, and F441Y rite-directed mutagenesis primer is:
Forward primer P3:5 '-GATTCTCTATGAGG
TATGGTCTGTTAAAGGTCG-3 ' (underscore is mutating alkali yl)
Reverse primer P4:5 '-CGACCTTTAACAGACC
ATACCTCATAGAGAATC-3 ' (underscore is mutating alkali yl)
The PCR reaction system is: 2 * PrimeSTAR
TMGC Buffer (contains Mg
2+) 25 μ L, dNTPs (each 2.5 mmol/L) 4 μ L, forward primer P3 (10 μ M) 1 μ L, reverse primer P4 (10 μ M) 1 μ L, template DNA 1 μ L, PrimeSTAR
TMHS DNA Polymerase(2.5 U/ μ l) 0.5 μ L adds distilled water to 50 μ L.
The pcr amplification condition is: 94 ℃ of denaturation 4 min; Carry out subsequently 30 circulations (94 ℃ of 10 s, 60 ℃ of 5 s, 72 ℃ of 4 min30s); 72 ℃ are extended 10 min; Last 4 ℃ of insulations.
PCR product warp
DpnI(is available from Canadian Fermentas company) digestion, transform escherichia coli jm109 competent cell, competent cell is after LB solid medium (containing 100 μ g/mL penbritins) overnight incubation, choosing mono-clonal cultivates in LB liquid nutrient medium (containing 100 μ g/mL penbritins), rear extraction plasmid, the mutant plasmid order-checking is correct.
, mutant enzyme expression and preparation:
Mutant plasmid F441Y/pT7-7 is transformed e. coli bl21 (DE3) cell, selecting transformant 37 ℃ of liquid culture in LB substratum (containing 100 μ g/mL penbritins) spends the night, 37 ℃ of rear access TB fermentation broth (containing 100 μ g/mL penbritins) are cultivated behind 2 h with 4 mg/L IPTG(isopropylthio-β-D galactosides) induce, be cooled to 25 ℃ of constant temperature culture 20 h.
Fermented liquid is in 4 ℃, and centrifugal 10 min of 8000 rpm collect thalline, uses the potassium phosphate buffer of pH 6.5 50mmol/L of equal volume to redissolve.Water-bath 30min in 80 ℃ of shaking baths, the centrifugal 20min of rear 10000rpm removes precipitation, collects supernatant liquor, obtains purer mutant enzyme F441Y.
Embodiment 3: the present embodiment explanation utilizes mutant enzyme to transform the optimum temperuture that lactose generates oligomeric galactose.
As shown in Figure 1, the suitableeest enzymatic conversion temperature of wild-type beta-galactosidase enzymes is 75 ℃, and as shown in Figure 2, the optimum temperuture of mutant enzyme F441Y is 70 ℃.
Embodiment 4: the present embodiment explanation utilizes mutant enzyme to transform the optimal pH that lactose generates oligomeric galactose.
As shown in Figure 3, the suitableeest enzymatic conversion pH of wild-type beta-galactosidase enzymes is 6.0, and as shown in Figure 4, the pH of mutant enzyme F441Y is 6.5.
Embodiment 5: the productive rate of present embodiment explanation HPLC methods analyst oligomeric galactose.
In the reaction solution, the tetrose in the oligomeric galactose, trisaccharide and the disaccharides amount in product adopts HPLC to determine.The chromatographic condition of measuring trisaccharide and tetrose is: Agilent 1200 HPLC chromatographic instruments, Agilent automatic sampler, chromatographic column Bio-rad Aminex HPX-87H (7.8 mm * 300 mm), Agilent 2410 differential detectors; Moving phase is the 5mmol/L dilution heat of sulfuric acid, flow velocity 0.8 mL min
-150 ℃ of column temperatures.
The chromatographic condition of measuring disaccharides is: Agilent 1200 HPLC chromatographic instruments, Agilent automatic sampler, chromatographic column Thermo Aps-2 HYPERSIL (4.6 mm * 250 mm), Agilent 2410 differential detectors; Moving phase (V/V) is 70% acetonitrile solution, flow velocity 0.8 mL min
-130 ℃ of column temperatures.
The mutant enzyme that the said mutation body surface is reached acquisition is compared with wild enzyme, can find, mutant F441Y has realized the raising of oligomeric galactose trisaccharide and tetrose content, and whole output reaches 61%.
Sequence table
<110〉Southern Yangtze University
<120〉mutant of a kind of beta-galactosidase enzymes and its preparation method and application
<160> 4
<170> PatentIn version 3.3
<210> 1
<211> 29
<212> DNA
<213〉artificial synthesized sequence
<220>
<223〉according to the gene order design, be used for gene amplification.
<400> 1
gtctgcatat gtactcattt ccaaatagc 29
<210> 2
<211> 31
<212> DNA
<213〉artificial synthesized sequence
<220>
<223〉according to the gene order design, be used for gene amplification.
<400> 2
gaatctcgag ttagtgcctt aatggcttta c 31
<210> 3
<211> 33
<212> DNA
<213〉artificial synthesized sequence
<220>
<223〉according to the gene order design, be used for gene amplification.
<400> 3
gattctctat gaggtatggt ctgttaaagg tcg 33
<210> 4
<211> 33
<212> DNA
<213〉artificial synthesized sequence
<220>
<223〉according to the gene order design, be used for gene amplification.
<400> 4
cgacctttaa cagaccatac ctcatagaga atc 33
Claims (4)
1. the mutant of a beta-galactosidase enzymes, it is characterized in that near the phenylalanine betagalactosidase activity center of sulphur ore deposit sulfolobus solfataricus (Sulfolobus solfataricus) is sported tyrosine, the aminoacid sequence of the gene lacS genes encoding of the beta-glycosidase of sulphur ore deposit sulfolobus solfataricus is identical in the aminoacid sequence of the beta-galactosidase enzymes of described sulphur ore deposit sulfolobus solfataricus and the ncbi database, the lacS gene is numbered AE006641, and described beta-galactosidase enzymes mutant is that 441 amino acids phenylalanines sport tyrosine.
2. the preparation method of mutant claimed in claim 1 is characterized in that determining the mutational site on the basis of sulphur ore deposit sulfolobus solfataricus beta-galactosidase enzymes crystalline structure; The mutant primer of design rite-directed mutagenesis carries out rite-directed mutagenesis take the carrier that carries beta-galactosidase gene as template and makes up mutant plasmid; Mutant plasmid is transformed e. coli bl21 (DE3) cell, the positive monoclonal of selecting after the checking carries out fermentation culture, 25 ℃ of constant temperature culture are to 24h, collecting cell, suspend with damping fluid after, 80 ℃ of water-bath thermal treatment 30min, the centrifuging and taking supernatant obtains mutant F441Y, and described mutational site is the 441st amino acids phenylalanine; Described mutant primer is:
P3:5’-GATTCTCTATGAGG
TATGGTCTGTTAAAGGTCG-3’;
P4:5’-CGACCTTTAACAGACC
ATACCTCATAGAGAATC-3’。
3. method according to claim 2 is characterized in that the described carrier that carries beta-galactosidase enzymes is pUC series, pET series, pT7-7, or any among the pGEX.
4. the application of the described mutant of claim 1 is characterized in that optimum temperuture is 70 ℃, and optimal pH is 6.5, and oligomeric galactose output reaches 61%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102473383A CN102337254B (en) | 2011-08-26 | 2011-08-26 | Mutant of beta-galactosidase and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102473383A CN102337254B (en) | 2011-08-26 | 2011-08-26 | Mutant of beta-galactosidase and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102337254A CN102337254A (en) | 2012-02-01 |
CN102337254B true CN102337254B (en) | 2013-04-17 |
Family
ID=45513206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102473383A Active CN102337254B (en) | 2011-08-26 | 2011-08-26 | Mutant of beta-galactosidase and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102337254B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102586312B (en) * | 2012-02-27 | 2014-07-09 | 江南大学 | Method for expressing intracellular protein matrix and application thereof |
CN103805581B (en) * | 2012-11-15 | 2015-06-17 | 中国科学院微生物研究所 | Beta-glycosidase mutant and coding gene thereof, and application thereof in producing ginsenoside CK |
CN103275953B (en) * | 2013-06-25 | 2014-06-18 | 山东大学 | Beta-galactosidase with broadened nucleoside substrate specificity |
EP4279604A3 (en) * | 2013-09-30 | 2024-03-06 | Amano Enzyme Inc. | Modified beta-galactosidase |
CN103881994B (en) | 2014-04-14 | 2020-03-27 | 中国农业科学院生物技术研究所 | β -galactosidase mutant with high transglycosidic activity and preparation method and application thereof |
CN105132446A (en) * | 2015-09-23 | 2015-12-09 | 昆明理工大学 | Promoter screening system |
CN105754969A (en) * | 2016-04-01 | 2016-07-13 | 北京农学院 | Beta-galactosidase mutant and related biological material and application thereof |
CN107937365B (en) * | 2018-01-15 | 2020-03-24 | 江南大学 | β -galactosidase mutant and preparation method and application thereof |
CN114214304B (en) * | 2021-10-20 | 2023-07-18 | 江南大学 | Beta-galactosidase mutant with improved GOS conversion rate and application thereof |
CN113980936B (en) * | 2021-10-20 | 2023-07-25 | 江南大学 | Beta-galactosidase mutant and application thereof in preparation of long-chain GOS |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1368300A (en) * | 1999-07-09 | 2001-01-30 | Universite De Liege | Cold-active beta galactosidase, the process for its preparation and the use thereof |
JP2003274991A (en) * | 2002-03-20 | 2003-09-30 | Nippon Origo Kk | Method for producing galactooligosaccharide |
CN101597614A (en) * | 2008-11-24 | 2009-12-09 | 中国农业科学院生物技术研究所 | Coding beta-galactosidase gene and expression thereof and application |
CN102115718A (en) * | 2010-12-16 | 2011-07-06 | 南京工业大学 | Recombinant strain for expressing beta-galactosidase and construction method and application thereof |
-
2011
- 2011-08-26 CN CN2011102473383A patent/CN102337254B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1368300A (en) * | 1999-07-09 | 2001-01-30 | Universite De Liege | Cold-active beta galactosidase, the process for its preparation and the use thereof |
JP2003274991A (en) * | 2002-03-20 | 2003-09-30 | Nippon Origo Kk | Method for producing galactooligosaccharide |
CN101597614A (en) * | 2008-11-24 | 2009-12-09 | 中国农业科学院生物技术研究所 | Coding beta-galactosidase gene and expression thereof and application |
CN102115718A (en) * | 2010-12-16 | 2011-07-06 | 南京工业大学 | Recombinant strain for expressing beta-galactosidase and construction method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102337254A (en) | 2012-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102337254B (en) | Mutant of beta-galactosidase and preparation method and application thereof | |
CN102876650B (en) | Pullulan enzymatic mutant and preparation method thereof | |
CN102787130B (en) | Acid and high temperature resistant alpha-amylase, and its gene, engineering bacterium and preparation method | |
CN102676480B (en) | Method for producing extracellular pullulanase by applying auto-induction culture medium and dual-temperature control strategy | |
CN111534503B (en) | Application of Haloferrila sp | |
CN101503680B (en) | Mutant of cyclodextrin glucosyl transferase having highly beta-cyclodextrin yielding property and mutation method | |
CN102994468B (en) | Cyclodextrin glycosyl transferase with improved maltodextrin substrate specificity and preparation method thereof | |
CN103468624B (en) | Genetic engineering bacteria used for high efficient production of mycose | |
CN103249832B (en) | Utilize new the producing succinic acid mutant microorganism and utilize its method producing succinic acid of sucrose and glycerol simultaneously | |
CN107142253A (en) | A kind of high catalytic efficiency and fire resistant xylanase mutant and its preparation method and application | |
CN104531629A (en) | Cyclodextrin glucosyltransferase mutant for improving AA-2G conversion rate | |
CN110066777A (en) | A kind of endoinulase and its application in production oligofructose | |
CN103555690A (en) | Novel fructosidase as well as encoding gene and applications thereof | |
CN105039374B (en) | A kind of starch induction type recombined bacillus subtilis and preparation method and application | |
Li et al. | Efficient preparation of soluble inducer for cellulase production and saccharification of corn stover using in-house generated crude enzymes | |
CN104130967B (en) | One plant of coexpression L lactic dehydrogenase and the Escherichia coli of hydrogenlyase and its construction method and application | |
CN103122341B (en) | Cyclodextrin glycosyl transferase with improved maltodextrin substrate specificity and preparation method thereof | |
CN105219746B (en) | A kind of yclodextrin glycosyltransferase mutant for being inhibited to weaken by beta-cyclodextrin | |
CN103614303B (en) | A kind of Li's Trichoderma strains of expressing saccharifying enzyme | |
CN104046586A (en) | Genetically engineered bacteria and application of genetically engineered bacteria to production of (2R, 3R)-2,3-butanediol | |
CN104911158A (en) | Cyclodextrin glucosyltransferase mutant with high beta-cyclizing activity | |
CN103555685A (en) | Mutation method for enhancing beta-cyclodextrin production capacity of beta-cyclodextrin glycosyltransferase | |
CN101503681A (en) | Mutant of cyclodextrin glucosyl transferase having highly alpha-cyclodextrin yielding property and mutation method | |
CN103966180A (en) | Method for improving cyclization activity of cyclodextrin glucosyltransferase | |
CN103740669A (en) | Method for improving beta-cyclodextrin production capability of cyclodextrin glycosyltransferase by calcium ion binding site amino acid residue mutation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |